2'-fluorothymidine has been researched along with Benign Neoplasms in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (16.67) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 6 (50.00) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alauddin, MM | 1 |
| Collins, JM; Douglas, KA; Jones, SK; Lawhorn-Crews, JM; Mangner, TJ; McHugh, CI; Modi, D; Shields, AF | 1 |
| Emerick, LE; Krohn, KA; Plotnik, DA; Schwartz, JL; Unadkat, JD | 1 |
| Grierson, JR; Jordan, R; Krohn, KA; Schwartz, JL; Tamura, Y | 1 |
| Collins, JM; Douglas, K; Mangner, TJ; Muzik, O; Shields, AF; Sloan, A; Sun, H; Vaishampayan, U | 1 |
| Douglas, KA; Lawhorn-Crews, JM; Shields, AF; Tehrani, OS | 1 |
| Collins, JM; Katki, AG; Klecker, RW | 1 |
| Cheng, YC | 1 |
| Hill, DL; Nan, L; Oliver, P; Rhie, JK; Wang, H; Wang, S; Wang, Z; Zhang, R | 1 |
| Abbruzzese, JL; Castellanos, AM; Krakoff, IH; Legha, SS; Levy, JK; Raber, MN; Schmidt, S | 1 |
| Burchenal, JH; Fanucchi, MP; Fox, JJ; Leyland-Jones, B; Watanabe, KA; Young, CW | 1 |
| Krohn, KA; Mankoff, DA; Shields, AF | 1 |
2 review(s) available for 2'-fluorothymidine and Benign Neoplasms
| Article | Year |
|---|---|
Journey of 2'-deoxy-2'-fluoro-5-methyl-1-β-D-arabinofuranosyluracil (FMAU): from Antiviral Drug to PET Imaging Agent.
Topics: Animals; Antiviral Agents; Arabinofuranosyluracil; Carbon Radioisotopes; Contrast Media; Fluorine Radioisotopes; Humans; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2018 |
PET imaging of cellular proliferation.
Topics: Cell Division; Humans; Neoplasms; Positron-Emission Tomography; Thymidine | 2005 |
1 trial(s) available for 2'-fluorothymidine and Benign Neoplasms
| Article | Year |
|---|---|
Imaging DNA synthesis with [18F]FMAU and positron emission tomography in patients with cancer.
Topics: Adult; Aged; Arabinofuranosyluracil; Biomarkers, Tumor; DNA, Neoplasm; Female; Humans; Male; Metabolic Clearance Rate; Middle Aged; Neoplasms; Organ Specificity; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution | 2005 |
9 other study(ies) available for 2'-fluorothymidine and Benign Neoplasms
| Article | Year |
|---|---|
Effects of capecitabine treatment on the uptake of thymidine analogs using exploratory PET imaging agents:
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Arabinofuranosyluracil; Capecitabine; Dideoxynucleosides; Female; Humans; Male; Middle Aged; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2016 |
Different modes of transport for 3H-thymidine, 3H-FLT, and 3H-FMAU in proliferating and nonproliferating human tumor cells.
Topics: Arabinofuranosyluracil; Biological Transport; Cell Line, Tumor; Cell Proliferation; Dideoxynucleosides; Equilibrative Nucleoside Transport Proteins; Humans; Kinetics; Neoplasms; Positron-Emission Tomography; Thymidine; Tritium | 2010 |
Monitoring tumor cell proliferation by targeting DNA synthetic processes with thymidine and thymidine analogs.
Topics: Animals; Arabinofuranosyluracil; Cell Division; Cell Line, Tumor; Dideoxynucleosides; DNA; Drug Delivery Systems; Humans; Metabolic Clearance Rate; Mice; Neoplasm Staging; Neoplasms; Radiopharmaceuticals; Thymidine; Thymidine Kinase; Tomography, Emission-Computed; Tritium | 2003 |
Tracking cellular stress with labeled FMAU reflects changes in mitochondrial TK2.
Topics: Arabinofuranosyluracil; Cell Line, Tumor; Humans; Mitochondria; Neoplasms; Oxidative Stress; Radionuclide Imaging; Radiopharmaceuticals; Thymidine Kinase; Tritium | 2008 |
Suicide prodrugs activated by thymidylate synthase: rationale for treatment and noninvasive imaging of tumors with deoxyuridine analogues.
Topics: Animals; Arabinofuranosyluracil; Cell Division; DNA; Floxuridine; Fluorine Radioisotopes; Humans; Methylation; Mice; Neoplasms; Phosphorylation; Prodrugs; Thymidylate Synthase; Tumor Cells, Cultured | 1999 |
Potential use of antiviral L(-)nucleoside analogues for the prevention or treatment of viral associated cancers.
Topics: Animals; Antiviral Agents; Arabinofuranosyluracil; Dioxolanes; Hepatitis B virus; Herpesvirus 4, Human; Humans; Neoplasms; Nucleosides; Stereoisomerism; Structure-Activity Relationship; Uracil; Virus Diseases; Zalcitabine | 2001 |
Radiolabeled 2'-fluorodeoxyuracil-beta-D-arabinofuranoside (FAU) and 2'-fluoro-5-methyldeoxyuracil-beta -D-arabinofuranoside (FMAU) as tumor-imaging agents in mice.
Topics: Animals; Arabinofuranosyluracil; DNA, Neoplasm; Humans; Mice; Mice, SCID; Muscle, Skeletal; Neoplasm Transplantation; Neoplasms; Radiopharmaceuticals; Spleen; Thymidine; Tissue Distribution; Tomography, Emission-Computed; Transplantation, Heterologous | 2002 |
Phase I trial of 1-(2'-deoxy-2'-fluoro-1-beta-D-arabinofuranosyl)-5-methyluracil (FMAU) terminated by severe neurologic toxicity.
Topics: Adult; Aged; Antineoplastic Agents; Arabinofuranosyluracil; Colonic Neoplasms; Drug Evaluation; Electroencephalography; Female; Fibrosarcoma; Hematologic Diseases; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Nervous System Diseases; Nervous System Neoplasms | 1989 |
Phase I trial of 1-(2'-deoxy-2'-fluoro-1-beta-D-arabinofuranosyl)-5-methyluracil (FMAU).
Topics: Adult; Aged; Antineoplastic Agents; Arabinofuranosyluracil; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Central Nervous System Diseases; Drug Evaluation; Female; Humans; Leukocyte Count; Lung Neoplasms; Male; Middle Aged; Nausea; Neoplasms; Platelet Count; Uridine; Vomiting | 1985 |